SEC Filing Summary for Akebia Therapeutics, Inc. - Form 4 Filing

This Form 4 filing reports a transaction by Erik Ostrowski, SVP, CFO, CBO & Treasurer of Akebia Therapeutics, Inc. On June 29, 2026, Ostrowski executed a "sell to cover" transaction involving 56,019 shares of Common Stock at a price of $1.11 per share. This transaction was conducted to cover tax withholding obligations related to the vesting of restricted stock units granted on June 28, 2024. The sale was executed automatically based on pre-established instructions. Following this transaction, Ostrowski holds 616,616 shares of Common Stock. The filing also notes that the transaction was subject to Section 16 reporting requirements.